• ورود به سامانه
      مشاهده مورد 
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Iranian Journal of Pharmaceutical Research
      • Volume 16, Issue 3
      • مشاهده مورد
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Iranian Journal of Pharmaceutical Research
      • Volume 16, Issue 3
      • مشاهده مورد
      JavaScript is disabled for your browser. Some features of this site may not work without it.

      Anticancer Activity of Curcumin-Loaded PLGA Nanoparticles on PC3 Prostate Cancer Cells

      (ندگان)پدیدآور
      azandeh, saeedAbbaspour, MohammadrezaKhodadadi, AliKhorsandi, Layasadatorazizadeh, MahmoudHeidari-Moghadam, Abbas
      Thumbnail
      دریافت مدرک مشاهده
      FullText
      اندازه فایل: 
      1.876 مگابایت
      نوع فايل (MIME): 
      PDF
      نوع مدرک
      Text
      Research article
      زبان مدرک
      English
      نمایش کامل رکورد
      چکیده
      Curcumin (Cur) has been found to be very efficacious against many different types of cancercells. However, the major disadvantage associated with the use of Cur is its low systemicbioavailability. Our present work investigated the toxic effect of encapsulation of Cur in PLGA(poly lactic-coglycolic acid) nanospheres (NCur) on PC3 human cancer prostate cell. In thepresent study, we have investigated the effects of NCur on growth, autophagia, and apoptosisin PC3 cells, respectively, by MTT assay, fluorescence microscopy, and Flow cytometry. MTTassays revealed that the NCur at the concentration of 25 μg/mL for 48 h were able to exert a morepronounced effect on the PC3 cells as compared to free Cur. Apoptotic index was significantlyincreased in NCur-treated cells compared to free Cur. The percentage of autophagic cells (LC3-II positive cells) was also significantly increased in NCur treatment in comparison to free Cur.These data indicate that the NCur has considerable cytotoxic activity more than Cur on PC3cell lines, which is mediated by induction of both apoptotic and autophagic processes. Thus,NCur has high potential as an adjuvant therapy for clinical application in prostate cancer.
      کلید واژگان
      Programmed cell death
      Prostate cancer
      Curcumin
      Nanoparticles
      PLGA
      Pharmacutical biotechnology

      شماره نشریه
      3
      تاریخ نشر
      2017-07-01
      1396-04-10
      ناشر
      School of Pharmacy, Shahid Beheshti University of Medical Sciences
      سازمان پدید آورنده
      Cell and Molecular Research Center, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
      Targeted Drug Delivery Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
      Department of Immunology and Cancer, Petroleum Pollutants, Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
      Cell and Molecular Research Center, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
      Cell and Molecular Research Center, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
      Cell and Molecular Research Center, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

      شاپا
      1735-0328
      1726-6890
      URI
      https://dx.doi.org/10.22037/ijpr.2017.2097
      http://ijpr.sbmu.ac.ir/article_2097.html
      https://iranjournals.nlai.ir/handle/123456789/313296

      مرور

      همه جای سامانهپایگاه‌ها و مجموعه‌ها بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌هااین مجموعه بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌ها

      حساب من

      ورود به سامانهثبت نام

      تازه ترین ها

      تازه ترین مدارک
      © کليه حقوق اين سامانه برای سازمان اسناد و کتابخانه ملی ایران محفوظ است
      تماس با ما | ارسال بازخورد
      قدرت یافته توسطسیناوب